The tumor lysis syndrome in a child with multicentric castleman disease

Journal of Pediatric Hematology/Oncology

Volumn 32, Issue 3, 2010, Pages 247-249

  Allen, Holley F ^a   Mehrotra, Sanjana P ^a   Richardson, Matthew W ^a  

^a BAYSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPREDNISOLONE; PREDNISONE; RASBURICASE; RITUXIMAB;

ADOLESCENT; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DRUG MEGADOSE; HUMAN; HUMAN TISSUE; LABORATORY TEST; LETTER; LYMPH NODE BIOPSY; MALE; MULTICENTRIC CASTLEMAN DISEASE; NEPHROTIC SYNDROME; PHYSICAL EXAMINATION; PRIORITY JOURNAL; TUMOR LYSIS SYNDROME;

ADOLESCENT; GIANT LYMPH NODE HYPERPLASIA; HUMANS; MALE; TOMOGRAPHY, X-RAY COMPUTED; TUMOR LYSIS SYNDROME;

EID: 77951030834     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3181cef45a     Document Type: Letter

References (8)

1. Dham A, Peterson BA. Castleman disease. Curr Opin Hematol. 2007;14:354-359.
2. Cairo MS, Bishop M. Tumour lysis syndrome: new therapeutic strategies and classification. Br J Haematol. 2004;127: 3-11.
3. Parez N, Bader-Meunier B, Roy CC, et al. Pediatric Castleman disease: report of seven cases and review of the literature. Eur J Pediatr. 1999;158:631-637.
4. Sugimoto T, Ito J, Takeda N, et al. A case of Castleman's disease complicated with nephrotic syndrome due to glomerulopathy mimicking membranoproliferative glomerulonephritis. Am J Med Sci. 2008; 335:495-498.
5. Lee K, Lee K-W, Choi IS, et al. Multicentric Castleman's disease complicated by tumor lysis syndrome. Ann Hematol. 2004; 83:722-725.
6. Ralph R, Adrogue HE, Dolson G, et al. Acute renal failure due to tumor lysis syndrome in a HIV seropositive patient with Castleman's disease. Nephrol Dial Transplant. 2004;19:1937.
7. Hummel M, Reiter S, Adam K, et al. Effective treatment and prophylaxis of hyperuricemia and impaired renal function in tumor lysis syndrome with low doses of rasburicase. Eur J of Haematol. 2008;80: 331-336.
8. Trifilio S, Gordon L, Singhal S, et al. Reduced-dose rasburicase (recombinant xanthine oxidase) in adult cancer patients with hyperuricemia. Bone Marrow Transplantation. 2006;37:997-1001.